Brookfield Infra (BIP) Q4 2025 Earnings Transcript

Blackbaud reported 2025 organic revenue of $1.128 billion, up 5.5% year over year, with adjusted EBITDA of $405 million (+8% adjusted) and adjusted free cash flow of $208 million, while retiring about 8% of shares and reducing net leverage to 2.5x. Management guided 2026 organic revenue growth of 4%-4.5%, adjusted EBITDA of $430 million-$438 million, and EPS of $5.15-$5.25, crossing $5 for the first time, while flagging no material AI revenue in guidance but highlighting new AI product upside. The call also emphasized longer contract durations, a 50%+ free-cash-flow buyback commitment through 2030, and a first agentic AI product priced in the tens of thousands per year.

Analysis

BLKB is signaling a two-stage re-rating story: near-term earnings quality is improving, but the bigger catalyst is the market’s eventual willingness to underwrite AI as a monetizable workflow layer rather than a marketing feature. The first-order implication is that the stock can work even if AI contribution stays immaterial in 2026, because buybacks plus margin expansion should mechanically lift EPS faster than revenue; the second-order effect is that any early conversion of agentic products into paid add-ons could force consensus to re-anchor long-term growth above the current 4%-6% framing.

The most underappreciated support is capital intensity falling while financial flexibility rises. With leverage already moving lower and repurchases explicitly prioritized, the company is effectively turning modest top-line growth into outsized per-share compounding; that tends to favor valuation expansion if execution stays clean. The risk is that the market may initially treat the “plus” in long-term guidance as optionality with low probability, but if one or two agent products show measurable attach and transactional uplift by late 2026, the narrative can change quickly.

Competitive dynamics are also interesting: incumbent vertical SaaS peers without proprietary data moats or embedded workflow depth may be forced into either uneconomic AI bundling or defensive pricing. That said, the company’s long-duration cohort creates a subtle near-term headwind: bigger renewal cohorts and more multi-year contracts can smooth revenue but also delay the full monetization of pricing actions, so the upside may arrive back-half weighted rather than immediately. The contrarian miss is that this is less a pure AI story than a distribution-and-data story; if that remains true, the multiple could expand even before AI becomes a meaningful P&L contributor.

Key Decisions for Investors

• Long BLKB on a 3-6 month horizon into the back-half growth inflection; thesis is EPS leverage plus buybacks can outperform modest revenue deceleration, with upside if agentic attach becomes visible by Q3/Q4 2026.
• Buy BLKB call spreads (e.g., 6-12 month tenor, strikes targeting ~15%-25% upside) to express the re-rating from AI optionality with limited downside if management continues to de-emphasize near-term AI monetization.
• Pair long BLKB / short a lower-quality vertical SaaS peer with weaker data moats and weaker free cash flow conversion; the spread should work if the market rewards per-share compounding over headline growth.
• Add on any post-earnings weakness tied to the back-half weighted guide; the setup improves if the market underestimates the cash flow step-up and overweights the slower Q1/Q2 comp.
• Use downside hedges rather than outright shorts if already long: the key risk is not demand collapse but multiple compression if investors decide AI monetization is too far out to matter in 2026.